التفاصيل البيبلوغرافية
| العنوان: |
Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain. |
| المؤلفون: |
Moretti, Raffaella, Leger, Pierre-Louis, Besson, Valérie C., Csaba, Zsolt, Pansiot, Julien, Di Criscio, Lorena, Gentili, Andrea, Titomanlio, Luigi, Bonnin, Philippe, Baud, Olivier, Charriaut-Marlangue, Christiane |
| المصدر: |
Journal of Neuroinflammation; 4/28/2016, Vol. 13, p1-12, 12p |
| مصطلحات موضوعية: |
ISCHEMIA treatment, SILDENAFIL, NEONATOLOGY, BRAIN injuries, LABORATORY mice, GENE expression, THERAPEUTICS, ANIMAL experimentation, ANIMAL populations, BIOLOGICAL models, CELLS, CEREBRAL ischemia, IMMUNOHISTOCHEMISTRY, MICE, POLYMERASE chain reaction, PHOSPHODIESTERASE inhibitors, PHARMACODYNAMICS |
| مستخلص: |
Background: Perinatal ischemic stroke is the most frequent form of cerebral infarction in neonates; however, evidence-based treatments are currently lacking. We have previously demonstrated a beneficial effect of sildenafil citrate, a PDE-5 inhibitor, on stroke lesion size in neonatal rat pups. The present study investigated the effects of sildenafil in a neonatal mouse stroke model on (1) hemodynamic changes and (2) regulation of astrocyte/microglia-mediated neuroinflammation.Methods: Ischemia was induced in C57Bl/6 mice on postnatal (P) day 9 by permanent middle cerebral artery occlusion (pMCAo), and followed by either PBS or sildenafil intraperitoneal (i.p.) injections. Blood flow (BF) velocities were measured by ultrasound imaging with sequential Doppler recordings and laser speckle contrast imaging. Animals were euthanized, and brain tissues were obtained at 72 h or 8 days after pMCAo. Expression of M1- and M2-like microglia/macrophage markers were analyzed.Results: Although sildenafil (10 mg/kg) treatment potently increased cGMP concentrations, it did not influence early collateral recruitment nor did it reduce mean infarct volumes 72 h after pMCAo. Nevertheless, it provided a significant dose-dependent reduction of mean lesion extent 8 days after pMCAo. Suggesting a mechanism involving modulation of the inflammatory response, sildenafil significantly decreased microglial density at 72 h and 8 days after pMCAo. Gene expression profiles indicated that sildenafil treatment also modulates M1- (ptgs2, CD32 and CD86) and M2-like (CD206, Arg-1 and Lgals3) microglia/macrophages in the late phase after pMCAo. Accordingly, the number of COX-2(+) microglia/macrophages significantly increased in the penumbra at 72 h after pMCAo but was significantly decreased 8 days after ischemia in sildenafil-treated animals.Conclusions: Our findings argue that anti-inflammatory effects of sildenafil may provide protection against lesion extension in the late phase after pMCAo in neonatal mice. We propose that sildenafil treatment could represent a potential strategy for neonatal ischemic stroke treatment/recovery. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Neuroinflammation is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder